YUMA REGIONAL MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.5M
- Transactions
- 384
- Companies
- 40
- Average per transaction
- $3,966
Who reported the payments
| Novartis | $413,749 |
| Merck | $176,820 |
| Astrazeneca UK Limited | $163,609 |
| Regeneron | $119,354 |
| AstraZeneca | $93,450 |
| Surmodics, Inc. | $67,061 |
| Eli Lilly | $65,437 |
| Boston Scientific | $63,012 |
| AbbVie | $60,464 |
| Janssen Research & Development, LLC | $51,872 |
| Array Biopharma Inc | $35,900 |
| Angiodynamics, Inc. | $33,103 |
| Genmark Diagnostics, Inc. | $26,594 |
| Spectrum Pharmaceuticals Inc. | $25,094 |
| Linvatec Corporation | $23,569 |
| Smith+Nephew | $19,917 |
| Incyte Corporation | $16,605 |
| Genentech, Inc. | $14,642 |
| Mirati Therapeutics, Inc. | $12,555 |
| Stryker | $10,829 |
| Cordis Corporation | $5,844 |
| GE HealthCare | $5,275 |
| Medartis Inc. | $2,732 |
| Penumbra, Inc. | $2,000 |
| Medtronic | $1,959 |
| AVEO Pharmaceuticals, Inc. | $1,500 |
| Sysmex America, Inc. | $1,500 |
| Vitalant | $1,279 |
| Siemens Medical Solutions USA, Inc. | $1,217 |
| Abbott | $1,208 |
| Arrow International, Inc. | $1,190 |
| Qiagen, LLC | $770 |
| Otsuka America Pharmaceutical, Inc. | $750 |
| Genentech USA, Inc. | $750 |
| Johnson & Johnson | $750 |
| Steris Corporation | $250 |
| Cochlear Americas | $194 |
| Masimo Corporation | $138 |
| Grifols Diagnostic Solutions, Inc. | $48 |
| Olympus America Inc. | $36 |